(Press-News.org) There has been concern that common diabetes drugs could increase the risk of suicide and self-harm. In a new study, led by researchers at Karolinska Institutet and published in Jama Internal Medicine, no such risk increase was observed.
Drugs of the type GLP-1 analogues lower blood sugar levels and are used by millions of people worldwide. They are mainly used to treat diabetes, but drugs such as Ozempic have also been shown to be effective against obesity, which has increased their popularity.
At the same time, both American and European drug authorities have warned that there may be risks associated with the drugs.
Last year, the European Medicines Agency (EMA) launched an investigation following around 150 reported possible cases of suicidal thoughts and self-injury with use of GLP-1 analogues.
The investigation was completed in the spring and based on the limited data available at the time, it concluded that there were no obvious connections. Researchers at Karolinska Institutet can now further support this conclusion. They have analyzed large amounts of data from people treated with GLP-1 analogues in Sweden and Denmark .
"We found no clear link between the use of the drugs and an increased risk of suicide death, self-harm or depression and anxiety-related disorders. This is reassuring." says Björn Pasternak, principal researcher at the Department of Medicine, Solna, Karolinska Institutet, and one of the study's lead authors.
The data includes approximately 300,000 adults aged 18–84 who started treatment with either GLP-1 analogues or SGLT2 inhibitors, another type of diabetes medication, during the years 2013–2021.
After a mean follow-up period of just over two years, there was no apparent increase in the proportion of people who committed suicide, engaged in self-harm, or suffered from depression or anxiety-related disorders among users of GLP-1 receptor agonists.
Peter Ueda, assistant professor at the same department and one of the study's main authors, nevertheless emphasizes the importance of larger studies as more data is collected.
"It is important to specifically examine people with previous self-harm or suicidal thoughts as they are at increased risk and it is possible that the drug’s safety profile differs in this group," he says.
The study was conducted in collaboration with researchers in Denmark and mainly funded by Karolinska Institutet. Some of the researchers report conflicts of interest, see the study for more information.
Publication: "GLP-1 receptor agonists and risk of suicide death: nationwide cohort study in Sweden and Denmark", Peter Ueda, Jonas Söderling, Viktor Wintzell, Henrik Svanström, Laura Pazzagli, Björn Eliasson, Mads Melbye, Anders Hviid, Björn Pasternak. JAMA Internal Medicine, online September 3, 2024.
END
No link found between popular diabetes medication and suicide
2024-09-03
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Thousands of jellyfish clones are multiplying in B.C. lakes
2024-09-03
An invasive, freshwater jellyfish is popping up in B.C. waters in the thousands and future sightings could increase rapidly, according to UBC research.
The peach blossom jellyfish clones have been spotted in 34 places in B.C., its furthest northern range in North America, and a recent paper predicts sightings and the number of locations will increase by the end of the decade as climate change extends this range.
Dr. Florian Lüskow, who completed the research during his postdoctoral fellowship ...
Infertility challenges amongst endangered wild songbird population revealed in new study
2024-09-03
A new study using 10 years of data has provided the most comprehensive estimate of infertility rates to date in a threatened wild animal population
Researchers from the University of Sheffield found infertility accounts for 17 per cent of hatching failure in an endangered songbird, the hihi, with the majority of hatching failure being caused by embryo death
This is the first study to find a link between small population size, sex ratio bias, and reduced fertilisation rates in wild animals
By considering the impacts of population size and sex ratio on fertility, conservationists can better manage the numbers and composition of animals in populations ...
Representatives from NASA, ESA, JAXA, ASI, KASA meet during COSPAR 2024 to reinforce cooperation and coordination for future missions to the asteroid Apophis
2024-09-03
Each agency representative presented the status of their current involvement in current and future planning for missions to Apophis (including extended mission for OSIRIS-REx, renamed OSIRIS-APEX, for NASA and the RAMSES mission for ESA) as well as the existing partnerships and mutual involvement in other agency’s missions, e.g. the infrared camera provided by JAXA in ESA’s mission Hera. Concepts to fly to Apophis, as well as reuse of existing payloads, spare parts and hardware, coordination of arrival time at Apophis of the different spacecraft, techniques to be demonstrated, ...
Vision-based ChatGPT shows deficits interpreting radiologic images
2024-09-03
OAK BROOK, Ill. – Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study’s results were published today in Radiology, a journal of the Radiological Society of North America (RSNA).
Chat GPT-4 Vision is the first version of the large language model that can interpret both text and images.
“ChatGPT-4 has shown promise for assisting radiologists in tasks such as simplifying patient-facing radiology reports and identifying ...
Minimal ADHD risk from prenatal cannabis use new study reveals
2024-09-03
A new study reveals nuanced findings on the neuropsychiatric risks of prenatal cannabis exposure. The research found a slight increase in the risk of ADHD and a heightened vulnerability to cannabis use in offspring. These results highlight the need for continued caution and further investigation into the long-term effects of cannabis use during pregnancy.
A new study led by Prof. Ilan Matok and Hely Bassalov PharmD from the Department of Clinical Pharmacy at the School of Pharmacy in the Faculty of Medicine at Hebrew University in collaboration ...
Study suggests gun-free zones do not attract mass shootings
2024-09-03
Gun-free zones have often been blamed for making schools, malls and other public areas more attractive to shooters; however, there have been no quantitative studies examining those claims. Now, in a first of its kind study published in The Lancet Regional Health Americas, researchers at UC Davis Health and other institutions have shown that gun-free zones may, in fact, reduce the risk of mass shootings.
"Our most significant finding is that gun-free zones don't attract active shooters,” said the study’s first author, Paul Reeping, ...
Mathematicians model a puzzling breakdown in cooperative behaviour
2024-09-03
Darwin was puzzled by cooperation in nature—it ran directly against natural selection and the notion of survival of the fittest. But over the past decades, evolutionary mathematicians have used game theory to better understand why mutual cooperation persists when evolution should favour self-serving cheaters.
At a basic level, cooperation flourishes when the costs to cooperation are low or the benefits large. When cooperation becomes too costly, it disappears—at least in the realm of pure mathematics. ...
Kessler Foundation scientists publish protocol for combining aerobic exercise and cognitive rehabilitation in multiple sclerosis
2024-09-03
East Hanover, NJ – September 3, 2024 – Researchers at Kessler Foundation have published a new clinical protocol examining the combination of aerobic exercise and cognitive rehabilitation to improve learning and memory in individuals with multiple sclerosis (MS) who have mobility disability. The article, “Rationale and methodology for examining the combination of aerobic exercise and cognitive rehabilitation on new learning and memory in persons with multiple sclerosis and mobility disability: Protocol for a randomized controlled trial,” was published online and will appear in print in Contemporary Clinical Trials, ...
New hope for progressive supranuclear palsy with innovative trial
2024-09-03
$75 million NIH grant could lead to the first effective drugs for a condition with few treatment options
A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.
Researchers hope the trial, which will be led by UC San Francisco and conducted at up to 50 sites nationwide, will lead to the development of new therapies. There are currently no drugs to stall the disease’s deadly progression.
The ...
Mass General Brigham Gene and Cell Therapy Institute launches RNA Therapeutics Core
2024-09-03
The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource to advance the use of RNA technologies within and beyond the Mass General Brigham research ecosystem. This new Core is dedicated to accelerating the exploration of novel therapeutic targets to effectively translate RNA-based medicines into clinical practice by leveraging advanced RNA vectors and delivery systems.
Until now, a Core of this kind has not existed within an academic setting. With this launch, the RNA Therapeutics Core enables ...